Alcon, the global leader in eye care, has announced the launch of the Clareon Family of intraocular lenses (IOLs) in India. Utilising Alcon’s most advanced IOL material in its 20+ years of IOL innovation, Clareon delivers consistent visual outcomes and exceptional clarity that lasts. Clareon’s clarity is born out of a glistening-free§ IOL material that has among the lowest levels of haze and subsurface nanoglistenings (SSNGs), compared to leading competitor IOLs.

Clareon IOLs are inserted using the next-generation, reusable Clareon Monarch IV Delivery System, which provides precise and controlled implantation and that was designed specifically for the new Clareon material.

More than 28 million cataract surgeries are performed each year in the world. With the ageing population and increased life expectancies, these surgeries are expected to increase 3-4% per year for the next 30 years, leading to an estimated 60 million global cataract surgeries annually by 2045.

The Clareon platform is available in India in two PCIOL technologies- Clareon PanOptix, which delivers exceptional clarity and offers spectacle independence across all distances with a patient satisfaction rate of 99.2%; and Clareon Vivity with wavefront-shaping X- WAVE technology, offering clinically proven exceptionally low rate of visual disturbances and unsurpassed clarity.